Drug Abuse News and Research

RSS

MGI Reveals Latest Updates at ESHG Conference in Glasgow

MGI Tech Co., Ltd. ("MGI"), a company committed to building core tools and technology to lead life science, held a Corporate Satellite Meeting and revealed significant local partnerships at the ESHG Conference in Glasgow.

From MGI 16 Jun 2023

Research reports associations between binge drinking and recreational cannabis laws

New research at Columbia University Mailman School of Public Health examined changes in binge drinking after the implementation of recreational cannabis laws.

15 Jun 2023

Measuring the receipt of medications and behavioral health services for AUD

Heavy drinking commonly begins in adolescence and is a known risk factor for the development of alcohol use disorder (AUD). Data from adult clinical trials suggest offering evidence-based medications for AUD to younger adults could promote their engagement in treatment and improve clinical outcomes.

15 Jun 2023

Males are significantly more vulnerable than females to overdose deaths

Men were significantly more vulnerable than women to overdose deaths involving opioid and stimulant drugs in 2020-2021, according to a new study analyzing death records data from across the United States. The study found that men had a 2–3 times greater rate of overdose mortality from opioids (like fentanyl and heroin) and psychostimulants (like methamphetamine and cocaine).

15 Jun 2023

New process for creating a “meta-cell overcomes the challenges of studying single-cell secrets

University of California, Irvine neuroscientists probing the gene changes behind Alzheimer's disease have developed a process of making a "meta-cell" that overcomes the challenges of studying a single cell.

13 Jun 2023

Study: Only 1 in 4 addiction treatment facilities caring for U.S. adolescents offer buprenorphine

Only 1 in 4 residential addiction treatment facilities caring for U.S. adolescents under 18 years old offer buprenorphine, a medication used to treat opioid use disorder, according to a new study.

13 Jun 2023

Researchers test a new way to deliver mental health therapy to people with addiction, aggressive behavior

Researchers from five colleges at Rochester Institute of Technology are testing a new way to deliver mental health therapy to people struggling with alcohol/drug addiction and aggressive behavior.

12 Jun 2023

First-in-class drug shows promise as a safe and effective treatment for cannabis use disorder

A first-in-class drug engineered to selectively inhibit the signaling pathway of the cannabinoid receptor shows promise as a safe and effective treatment for cannabis use disorder (CUD), a condition where a person is unable to control their cannabis use, even though it's causing problems in their lives.

8 Jun 2023

Study finds a dramatic increase in the use of non-LSD hallucinogens among young adults

Young adults ages 19 to 30 nearly doubled their past 12-month use of non-LSD hallucinogens in the United States from 2018 to 2021, according to a study by the University of Michigan and Columbia University.

8 Jun 2023

Recovery from addiction is a journey. There’s no one-and-done solution.

The atmosphere inside the Allen House is easygoing as residents circulate freely through the hallways, meet in group sessions, or gather on a large outdoor patio that features a dirt volleyball court with an oversize net.

6 Jun 2023

Reentry services for incarcerated people with substance use disorder may lower post-release risks

Contrary to expectations, the risk for relapses, overdoses and deaths related to substance use disorder didn't increase after a large-scale prison release in New Jersey, according to a Rutgers study.

2 Jun 2023

Study analyzes the effects of state-level policies on use of anti-opioid medication

States that want to increase access to buprenorphine, a lifesaving medication used to treat opioid use disorder, should consider efforts to enhance professional education and clinician knowledge, according to a new RAND Corporation study.

26 May 2023

$11.6 million NIDA grant supports the study of cannabis effects on HIV-infected brains

Weill Cornell Medicine has been awarded a five-year, $11.6 million grant from the National Institute on Drug Abuse of the National Institutes of Health to study the effects cannabis, including marijuana and compounds derived from it, may have on the brains of those living with HIV.

23 May 2023

Researchers identify brain signatures for chronic pain in a small group of individuals

For the first time, researchers have recorded pain-related data from inside the brain of individuals with chronic pain disorders caused by stroke or amputation (phantom limb pain).

22 May 2023

New Jersey's Medicaid reforms spurred increases in buprenorphine prescriptions to combat opioid addiction

Reforms to New Jersey's Medicaid program successfully spurred ongoing increases in buprenorphine prescriptions for the treatment of opioid addiction, according to a Rutgers analysis.

19 May 2023

Biosensor Versatility; From Analytical Chemistry to Diagnostics

At Pittcon 2023 in Philadelphia, Pennsylvania, we spoke to this year's recipient of the Ralph N. Adams Award in Analytical Chemistry, Professor Joseph Wang to discuss the versatility of biosensor technologies.

From Pittcon 18 May 2023

New NIH program seeks to discover and catalog the breadth of somatic mosaicism in human tissues

The National Institutes of Health is launching a new program, the Common Fund's Somatic Mosaicism Across Human Tissues Network, that aims to transform our knowledge of how much genetic variation there is in the cells and tissues throughout our bodies.

11 May 2023

Legal pot is more potent than ever — and still largely unregulated

Marijuana and other products containing THC, the plant's main psychoactive ingredient, have grown more potent and more dangerous as legalization has made them more widely available.

9 May 2023

New research to measure the impact of overdose prevention centers in the United States

NYU Langone Health and Brown University's School of Public Health today announced a grant award from the National Institute on Drug Abuse, part of the National Institutes of Health, to conduct research to measure the impact of some of the first publicly recognized overdose prevention centers (OPCs) in the United States, located in New York City and Providence, Rhode Island.

8 May 2023

Young men with cannabis use disorder have elevated risk of developing schizophrenia

Young men with cannabis (marijuana) use disorder have an increased risk of developing schizophrenia, according to a study led by researchers at the Mental Health Services in the Capital Region of Denmark and the National Institute on Drug Abuse (NIDA) at the National Institutes of Health.

4 May 2023

Drug Abuse News and Research

MGI Reveals Latest Updates at ESHG Conference in Glasgow

Research reports associations between binge drinking and recreational cannabis laws

Measuring the receipt of medications and behavioral health services for AUD

Males are significantly more vulnerable than females to overdose deaths

New process for creating a “meta-cell overcomes the challenges of studying single-cell secrets

Study: Only 1 in 4 addiction treatment facilities caring for U.S. adolescents offer buprenorphine

Researchers test a new way to deliver mental health therapy to people with addiction, aggressive behavior

First-in-class drug shows promise as a safe and effective treatment for cannabis use disorder

Study finds a dramatic increase in the use of non-LSD hallucinogens among young adults

Recovery from addiction is a journey. There’s no one-and-done solution.

Reentry services for incarcerated people with substance use disorder may lower post-release risks

Study analyzes the effects of state-level policies on use of anti-opioid medication

$11.6 million NIDA grant supports the study of cannabis effects on HIV-infected brains

Researchers identify brain signatures for chronic pain in a small group of individuals

New Jersey's Medicaid reforms spurred increases in buprenorphine prescriptions to combat opioid addiction

Biosensor Versatility; From Analytical Chemistry to Diagnostics

New NIH program seeks to discover and catalog the breadth of somatic mosaicism in human tissues

Legal pot is more potent than ever — and still largely unregulated

New research to measure the impact of overdose prevention centers in the United States

Young men with cannabis use disorder have elevated risk of developing schizophrenia

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News